1. Home
  2. RLYB vs SYNX Comparison

RLYB vs SYNX Comparison

Compare RLYB & SYNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RLYB
  • SYNX
  • Stock Information
  • Founded
  • RLYB 2018
  • SYNX 2005
  • Country
  • RLYB United States
  • SYNX Israel
  • Employees
  • RLYB N/A
  • SYNX N/A
  • Industry
  • RLYB Biotechnology: Pharmaceutical Preparations
  • SYNX
  • Sector
  • RLYB Health Care
  • SYNX
  • Exchange
  • RLYB Nasdaq
  • SYNX Nasdaq
  • Market Cap
  • RLYB 13.3M
  • SYNX 11.9M
  • IPO Year
  • RLYB 2021
  • SYNX 2024
  • Fundamental
  • Price
  • RLYB $0.29
  • SYNX $1.95
  • Analyst Decision
  • RLYB Hold
  • SYNX
  • Analyst Count
  • RLYB 4
  • SYNX 0
  • Target Price
  • RLYB $15.00
  • SYNX N/A
  • AVG Volume (30 Days)
  • RLYB 86.0K
  • SYNX 25.4K
  • Earning Date
  • RLYB 05-08-2025
  • SYNX 05-21-2025
  • Dividend Yield
  • RLYB N/A
  • SYNX N/A
  • EPS Growth
  • RLYB N/A
  • SYNX N/A
  • EPS
  • RLYB N/A
  • SYNX N/A
  • Revenue
  • RLYB $848,000.00
  • SYNX $9,893,000.00
  • Revenue This Year
  • RLYB N/A
  • SYNX $52.34
  • Revenue Next Year
  • RLYB N/A
  • SYNX N/A
  • P/E Ratio
  • RLYB N/A
  • SYNX N/A
  • Revenue Growth
  • RLYB N/A
  • SYNX 18.05
  • 52 Week Low
  • RLYB $0.22
  • SYNX $1.70
  • 52 Week High
  • RLYB $2.00
  • SYNX $6.49
  • Technical
  • Relative Strength Index (RSI)
  • RLYB 35.98
  • SYNX 43.27
  • Support Level
  • RLYB $0.29
  • SYNX $1.72
  • Resistance Level
  • RLYB $0.33
  • SYNX $1.84
  • Average True Range (ATR)
  • RLYB 0.02
  • SYNX 0.09
  • MACD
  • RLYB 0.02
  • SYNX 0.08
  • Stochastic Oscillator
  • RLYB 42.19
  • SYNX 85.35

About RLYB Rallybio Corporation

Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. The programs of the company are for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.

About SYNX Silynxcom Ltd.

Silynxcom Ltd is engaged in developing, manufacturing, marketing and selling ruggedized Personal Headset Devices as well as other communications accessories, all of which have been battlefield-tested and combat-proven. It specializes in developing the In-Ear Headset device, a subsegment of the Personal Headset Device market. The In-Ear Headset device is used in both in training and operations by the military, law enforcement, and disaster recovery industry professionals. It also develops, market and sell push-to-talk devices, communication controllers, and communication device cables and connectors.

Share on Social Networks: